Ghk-cu Cas：89030-95-5
New Products From This Supplier
GHK-CU is a naturally occurring tripeptide. It was first isolated from human plasma but can be found in saliva and urine. During wound healing, it may be freed from existing extracellular proteins via proteolysis.
GHK-Cu can be used as a skin antiaging agent. It could lead to the extracellular matrix accumulation increases in the rat wound model. Copper Peptide preparations were able to promote wound healing rates in diabetic ulcers and patients undergoing Mohs surgery. It may also improve the autocrine growth factor milieu in keloid fibroblasts. It can also be doped into It can also be doped into binary binary PBDB-T: ITIC to tune the crystallinity and phase separation of the active layer, improving the performance of polymer solar cells.
Brand: Soarwin
CAS No.: 89030-95-5
EC Number: *******-626-2
Molecular Formula: C14H21CuN6O4
Storage temp.: under inert gas (nitrogen or Argon) at 2–8 °C
Solubility: Soluble in DMSO
Business Nature
Manufacturer
Year Established
2025
Country/Region
Chongqing, China
Main Products
Chemical Reagents, And Chemical Raw Materials., Pharmaceutical Intermediates, Plant Extracts...
Payment Terms
Escrow, Cash, Western Union (WU), PayPal, Credit Card (CC), MoneyGram, Doc Against Acceptance (D/A), Doc Against Payment (D/P), Letter of Credit (L/C), Bank wire (T/T)
Chongqing Soarwin Technology Co., Ltd is located in Chongqing. It is an enterprise dedicated to the research, development, production, and sales of chemical reagents, pharmaceutical intermediates, plant extracts, and chemical raw materials. It is a pharmaceutical company guided by the global pharmaceutical market demand and integrates innovative drug research and development, industrialization, and market operation. At present, the company has submitted 10 domestic patents and 1 PCT patent (international patent); and obtained 7 invention patents. The company has strong technical strength, advanced equipment, a strict quality management system, and high-quality after-sales service.
